Zhan H. Wang
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Cognitive Triad and Depression: A Meta-Analysis of Cross-Sectional and Longitudinal Studies.
Journal: Clinical psychology & psychotherapy
Published: January 16, 2026
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.
Journal: Cell reports. Medicine
Published: October 21, 2025
PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.
Journal: Nature communications
Published: September 13, 2025
Effects of COVID-19 vaccination on irAEs and prognosis in lung cancer patients receive PD-(L)1 inhibitors.
Journal: Human vaccines & immunotherapeutics
Published: August 14, 2025
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.
Journal: Nature medicine
Published: July 22, 2025
Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions.
Journal: Biomarker research
Published: July 16, 2025
Association of Erythrocyte-Related Indices with Immune-Related Adverse Events and Survival of Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 15, 2025
Association of Ion Concentration with Immune-Related Adverse Events and Prognosis in Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitors.
Journal: Journal of Cancer
Published: June 30, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 25, 2025
A steric hindrance-regulated probe with single excitation dual emissions for self-adaptive detection of biothiols and H2S in human urine samples and living cells.
Journal: Journal of materials chemistry. B
Published: January 27, 2025
Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors.
Journal: Chinese medical journal
Published: October 06, 2024
Last Updated: 09/26/2026